Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).

@article{Watters2006AntimicrobialAO,
  title={Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).},
  author={Amy Watters and Ronald N. Jones and Jennifer A Leeds and Gerald A. Denys and H{\'e}lio S. Sader and Thomas R. Fritsche},
  journal={The Journal of antimicrobial chemotherapy},
  year={2006},
  volume={57 5},
  pages={914-23}
}
OBJECTIVES To evaluate the spectrum of activity and potency of LBM415, the first of the peptide deformylase inhibitor (PDFI) class to be developed for treatment of community-acquired respiratory tract infections and uncomplicated skin and soft tissue infections (uSSTI), against a large, contemporary international collection of targeted pathogens collected during 2003-2004. METHODS A total of 21,636 isolates were tested by reference broth microdilution methods as part of a longitudinal… CONTINUE READING
10 Citations
26 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis)

  • JonesRN, HS Sader, TR Fritsche
  • Diagn Microbiol Infect Dis
  • 2005
Highly Influential
3 Excerpts

Peptidedeformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene

  • PS Margolis, HackbarthCJ, YoungDC
  • Antimicrob Agents Chemother
  • 2000
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…